Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells.
about
Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interactionAntiviral cyclic D,L-alpha-peptides: targeting a general biochemical pathway in virus infections.Development of a novel efficient method to construct an adenovirus library displaying random peptides on the fiber knob.Use of in vivo phage display to engineer novel adenoviruses for targeted delivery to the cardiac vasculature.Enhancement of adenovirus vector entry into CD70-positive B-cell Lines by using a bispecific CD70-adenovirus fiber antibodyStructural analysis of a fiber-pseudotyped adenovirus with ocular tropism suggests differential modes of cell receptor interactions.Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells.The promise and potential hazards of adenovirus gene therapy.Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridgeEfficient amplification of chimeric adenovirus 5/40S vectors carrying the short fiber protein of Ad40 in suspension cell culturesInfectivity-selective oncolytic adenovirus developed by high-throughput screening of adenovirus-formatted libraryRole of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review)ENU-induced phenovariance in mice: inferences from 587 mutations.Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo.Recombinant adenovirus-mediated cytotoxic gene therapy of lymphoproliferative disorders: is CAR important for the vector to ride?Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity.Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds.Transductional targeting of adenovirus vectors for gene therapyCore labeling of adenovirus with EGFP.Increased susceptibility to DNA virus infection in mice with a GCN2 mutationMucosal vaccination by adenoviruses displaying reovirus sigma 1.Structure of human adenovirus.T-cell-biased immune responses generated by a mucosally targeted adenovirus-σ1 vaccinePeptide targeting of adenoviral vectors to augment tumor gene transferMembers of adenovirus species B utilize CD80 and CD86 as cellular attachment receptorsCurrent advances and future challenges in Adenoviral vector biology and targetingA chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1.Adenovirus fiber shaft contains a trimerization element that supports peptide fusion for targeted gene delivery.Flexibility of the adenovirus fiber is required for efficient receptor interaction.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy.Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein.Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid.Genetically targeted adenovirus vector directed to CD40-expressing cellsModification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer.Tropism modification of adenovirus vectors by peptide ligand insertion into various positions of the adenovirus serotype 41 short-fiber knob domain.Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IXThe effect of fiber truncations on the stability of adenovirus type 5.
P2860
Q28744246-6103564D-6618-453D-9FB5-F39E0AC6C139Q30788662-47746EE0-7A39-4B35-9ED9-FDCCDE3C9756Q31146926-126E3E7D-48CD-433F-88AA-70F3D3C108AEQ33456433-D0828A2B-FAA4-4A71-BC4E-3F56FA0AD7A7Q33851887-650667E6-A425-4579-97A5-4FD6B0EA6AC5Q33852217-E0B9FC12-B24C-4CEC-A0D5-4C43E32942AEQ33866165-264005C9-9502-4CB5-9E92-4C461AC173B4Q34219407-E44FF700-721B-4292-BD1F-7C0359CC2A8BQ34226547-6A95A731-61FD-4798-91E9-3A364244AB73Q34364465-3B9266B4-394C-462B-B90E-97704BD37E0DQ34432734-BE752DD4-BB1A-46EB-8A0F-0A57CC417219Q34433546-604DF434-1BE6-4ADA-8E56-E61B5820370BQ34457048-6DA4263F-6E4A-4C3F-8D7E-4A52DF4FBB36Q34465133-6117C6D7-C615-41D4-93A2-0CBD82B82BEFQ35061703-C2E3EF88-EFC7-4A4A-A1F1-B6C98E5C889DQ35139196-4E08E611-2184-4DF6-A36E-20C6C60126F5Q35156188-333073F5-F784-48F6-AB3C-4CB9179527C9Q35609035-ED1D952F-4292-4055-BB51-9EA483C12459Q35609040-16F489F6-695D-4AF2-B667-4A1392B7EFA4Q35689654-4ECA05BF-98C3-479E-8EFC-BBBF215417B4Q35705983-B78C3CA6-B34A-49A7-818E-5B5231563E8DQ35878314-EF7EE096-54FE-45ED-9E90-07DD2752B4D3Q35894806-CBC123E1-E850-4C71-AF6C-14058B7A3FB4Q36049440-A0A536E3-4CD6-4714-898D-9E4F6DA02CF6Q36387951-BB9EE3D5-CF0A-46EB-A015-EE91047AC178Q36463004-7B1CB937-4554-4E3A-9CC3-EDF7E4BB6F91Q37647461-8BD18241-5DFD-4F6E-8029-0F987F8EFB12Q38308865-6A04C565-1A7B-4068-AA97-CA12F816191FQ38353615-008C9FAB-B7B4-4FD3-84DB-3D8E4AF612A6Q38614156-6461A913-EF0D-4D80-A036-EDD5BF5E96EAQ38769919-1E4557E8-60BE-485F-B981-0535E0A4B385Q39601931-4A88D89C-F077-4D65-A0AC-303A52549754Q39819077-7890D53C-7A85-481C-BDA2-9D19E2C62615Q40012083-E21CBC5C-ADC8-487C-9D55-4854AE4F1133Q40055106-9BC1FB4C-5FBA-4BA0-8094-D02968FEAB51Q40189728-691BE8DF-3572-4BAA-ABCA-56E9A1919CE8Q40579221-91851B50-2068-41E3-8B83-69DA5859FFAFQ42209051-8ACCCA5F-B6DA-45EE-9304-2CD4035D087D
P2860
Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Adenovirus vector pseudotyping ...... arr virus-transformed B cells.
@en
type
label
Adenovirus vector pseudotyping ...... arr virus-transformed B cells.
@en
prefLabel
Adenovirus vector pseudotyping ...... arr virus-transformed B cells.
@en
P2093
P2860
P921
P1433
P1476
Adenovirus vector pseudotyping ...... arr virus-transformed B cells.
@en
P2093
D J Von Seggern
G R Nemerow
S C Stevenson
P2860
P304
P356
10.1128/JVI.74.1.354-362.2000
P407
P577
2000-01-01T00:00:00Z